News

Dr. Reddy's Laboratories Ltd. closed 17.37% short of its 52-week high of 1,420.20 rupees, which the company achieved on ...
Dr. Reddy's Laboratories and Lupin are recalling products in the US due to labeling and manufacturing issues. Dr. Reddy's is ...
Dr Reddys launches Atorvastatin Calcium Tablets in US Dr Reddys Laboratories has launched Atorvastatin Calcium Tablets, a bioequivalent of Lipitor in the US, reports Business Standard. Dr Reddy ...
Pharmaceutical layoffs planned? No, says Dr Reddy's Laboratories, as the drugmaker categorically denied media reports that has undertaken workforce reduction to cut costs by around 25 per cent.